Subtypes of Depressive Episodes According to ICD-10: Prediction of Risk of Relapse and SuicideKessing L.V.
Department of Psychiatry, University of Copenhagen, Rigshospitalet, Copenhagen, and Department of Psychiatric Demography, University of Aarhus, Psychiatric Hospital, Risskov, Denmark
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: The long-term predictive ability of the ICD-10 subtypes of depression with melancholic syndrome and depression with psychosis has not been investigated. Sampling and Methods: All patients in Denmark who had a diagnosis of a single depressive episode at their first ever discharge during a period from 1994 to 1999 were identified. The risk of relapse leading to readmission and the risk of committing suicide were compared for patients discharged with an ICD-10 diagnosis of a single depressive episode with and without melancholic syndrome and for patients with and without psychotic symptoms, respectively. Results: In all, 1,639 patients had a diagnosis of depressive episode without psychotic symptoms, 1,275 patients a diagnosis with psychotic symptoms, 293 a diagnosis without melancholic syndrome, and 248 a diagnosis with melancholic symptoms at first discharge. The risk of relapse leading to readmission was greater for patients with psychotic symptoms than for patients without, but no difference was found between the two groups in the risk of committing suicide during follow-up. No differences were found in the risk of relapse leading to readmission or suicide between patients with and without melancholic syndrome. Conclusions: The ICD-10 categorization into depression with and without psychotic symptoms seems to be clinically and prognostically useful, whereas the ICD-10 subtyping into melancholic and non-melancholic syndrome does not seem to have any long-term predictive value.
© 2003 S. Karger AG, Basel
World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, World Health Organization, 1992.
- Paykel ES: Mood disorders: Review of current diagnostic systems. Psychopathology 2002;35:94–99.
- Robins E, Guze SB: Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. Am J Psychiatry 1970;126:983–987.
- Kessing LV, Andersen PK, Mortensen PB, Bolwig TG: Recurrence in affective disorder. I. Case register study. Br J Psychiatry 1998;172:23–28.
- Kessing LV: Recurrence in affective disorder. II. Effect of age and gender. Br J Psychiatry 1998;172:29–34.
- Munk-Jorgensen P, Mortensen PB: The Danish Psychiatric Central Register. Dan Med Bull 1997;44:82–84.
Coryell W: Psychotic depression. J Clin Psychiatry 1996;57(suppl 3):27–31.
- Brockington IF, Helzer JE, Hillier VF, Francis AF: Definitions of depression: Concordance and prediction of outcome. Am J Psychiatry 1982;139:1022–1027.
- Robinson DG, Spiker DG: Delusional depression. A one year follow-up. J Affect Disord 1985;9:79–83.
- Baldwin RC: Delusional and non-delusional depression in late life. Evidence for distinct subtypes. Br J Psychiatry 1988;152:39–44.
Parker G, Hadzi-Pavlovic D, Hickie I, Mitchell P, Wilhelm K, Brodaty H, Boyce P, Eyers K, Pedic F: Psychotic depression: a review and clinical experience. Aust NZ J Psychiatry 1991;25:169–180.
- Flint AJ, Rifat SL: Two-year outcome of psychotic depression in late life. Am J Psychiatry 1998;155:178–183.
- Coryell W, Leon A, Winokur G, Endicott J, Keller M, Akiskal H, Solomon D: Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry 1996;153:483–489.
- Coryell W, Tsuang MT: Primary unipolar depression and the prognostic importance of delusions. Arch Gen Psychiatry 1982;39:1181–1184.
- Strober M, Carlson G: Bipolar illness in adolescents with major depression: Clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation. Arch Gen Psychiatry 1982;39:549–555.
- Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS: Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry 1995;152:385–390.
- Kendler KS: Mood-incongruent psychotic affective illness. A historical and empirical review. Arch Gen Psychiatry 1991;48:362–369.
- Coryell W, Tsuang MT, McDaniel J: Psychotic features in major depression. Is mood congruence important? J Affect Disord 1982;4:227–236.
- Wolfersdorf M, Keller F, Steiner B, Hole G: Delusional depression and suicide. Acta Psychiatr Scand 1987;76:359–363.
- Black DW, Winokur G, Nasrallah A: Effect of psychosis on suicide risk in 1,593 patients with unipolar and bipolar affective disorders. Am J Psychiatry 1988;145:849–852.
- Fawcett J, Scheftner WA, Fogg L, Clark DC, Young MA, Hedeker D, Gibbons R: Time-related predictors of suicide in major affective disorder. Am J Psychiatry 1990;147:1189–1194.
Kessing LV: The severity of depressive episodes according to ICD-10: Prediction of the risk of relapse and suicide. 2003, unpublished.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.